Hormone therapy naive patients planned to be treated by radical radiotherapy after 3-6 months of androgen suppression
Patients with low-high risk histologically confirmed localised disease are eligible, with WHO performance status 0-1.
You may not be if
Patients unsuitable for functional MRI of the prostate or gold seed fiducial marker insertion (e.g. patients unable to tolerate endorectal MRI examination).
No prior pelvic radiotherapy or radical prostatectomy, previous androgen therapy, patients unsuitable for radical radiotherapy, life expectancy \<10 years, previous active malignancy within last 5 years, co-morbid conditions likely to impact on the advisability of radical radiotherapy, full anticoagulation, other exclusions to MRI (e.g. hip prosthesis or fixation, claustrophobia, ferromagnetic implants).
Clareo Health | Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer
